Table 5.
Reported STI symptoms in the past month, among those with and without MGin urine, and gender
| MG-negative | MG-positive | OR | P-value | AOR | P-value | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Men | ||||||||||
| Any STI symptom: % (95% CI) | 7.3% | [6.1%,8.9%] | 5.6% | [1.3%,20.6%] | 0.75 | (0.17–3.35) | 0.706 | 0.68 | (0.15–3.09) | 0.619 |
| Pain, burning or stinging passing urine | 2.3% | [1.7%,3.2%] | 2.6% | [0.4%,16.7%] | 1.13 | (0.15–8.69) | 0.909 | 0.80 | (0.10–6.23) | 0.813 |
| More frequent urination | 2.5% | [1.8%,3.6%] | 0.0% | – | – | – | – | – | – | |
| Genital warts/lumps | 0.8% | [0.4%,1.5%] | 0.0% | – | – | – | – | – | – | |
| Genital ulcers/sores | 0.2% | [0.1%,0.6%] | 0.0% | – | – | – | – | – | – | |
| Penile discharge | 0.3% | [0.2%,0.7%] | 0.0% | – | – | – | – | – | – | |
| Painful testicles | 2.8% | [2.1%,3.7%] | 3.0% | [0.4%,19.0%] | 1.09 | (0.14–8.48) | 0.936 | 1.43 | (0.18–11.10) | 0.731 |
| Women | ||||||||||
| Any STI symptom: % (95% CI) | 25.7% | [23.7%,27.7%] | 43.8% | [26.7%,62.5%] | 2.26 | (1.05–4.84) | 0.037 | 2.15 | (0.92–5.00) | 0.077 |
| Pain, burning or stinging passing urine | 7.8% | [6.6%,9.0%] | 7.8% | [1.1%,38.2%] | 1.00 | (0.14–7.40) | 0.999 | 0.87 | (0.10–7.41) | 0.900 |
| More frequent urination | 5.2% | [4.3%,6.3%] | 8.6% | [1.5%,36.3%] | 1.72 | (0.28–10.49) | 0.558 | 1.49 | (0.22–10.15) | 0.682 |
| Genital warts/lumps | 0.8% | [0.5%,1.4%] | 0.0% | – | – | – | – | – | – | |
| Genital ulcers/sores | 0.7% | [0.4%,1.3%] | 1.8% | [0.3%,12.0%] | 2.73 | (0.34–22.18) | 0.347 | 2.13 | (0.27–16.76) | 0.470 |
| Abnormal vaginal discharge | 4.0% | [3.3%,4.9%] | 0.9% | [0.1%,6.3%] | 0.22 | (0.03–1.61) | 0.135 | 0.18 | (0.03–1.35) | 0.096 |
| Odorous vaginal discharge | 4.0% | [3.2%,5.0%] | 5.0% | [1.5%,15.7%] | 1.27 | (0.35–4.54) | 0.718 | 1.11 | (0.32–3.78) | 0.871 |
| Vaginal pain during sex | 6.7% | [5.6%,8.1%] | 9.1% | [2.7%,26.7%] | 1.39 | (0.38–5.12) | 0.618 | 1.29 | (0.34–4.83) | 0.706 |
| Bleeding between periods | 4.5% | [3.7%,5.5%] | 7.1% | [1.6%,25.9%] | 1.62 | (0.35–7.51) | 0.541 | 1.73 | (0.36–8.39) | 0.493 |
| Bleeding after sex | 2.7% | [2.0%,3.5%] | 14.4% | [4.4%,38.2%] | 6.15 | (1.64–23.09) | 0.007 | 5.78 | (1.43–23.34) | 0.014 |
| Lower abdominal / pelvic pain | 6.3% | [5.2%,7.7%] | 10.8% | [3.7%,27.6%] | 1.80 | (0.57–5.72) | 0.318 | 1.65 | (0.53–5.17) | 0.390 |
| Denominator (unweighted, weighted) | ||||||||||
| Men | (1849, 2222) | (24, 26) | ||||||||
| Women | (2578, 2215) | (48, 29) | ||||||||
Denominator is those aged 16–44 who reported at least one sexual partner, ever. MG-negative is the reference category.
AOR, adjusted odds ratio, adjusted for chlamydia, gonorrhoea, HR-HPV infection, and age.